Baseline CD4 stratum |
|
<200, 200-350, >350 |
<50, 50-200 |
<50; 50-200; 200-500; >500 |
|
|
Current CD4 stratum |
<200, 200-350 |
<200, 200-350, >350 |
|
<50; 50-200; 200-500; >500 |
|
|
Baseline viral load stratum |
|
|
|
>100,000; 30,001-100,000; 10,001-30,000; 3,001-10,000; 501-3,000; 0-500 |
|
|
Current viral load stratum |
|
|
|
>100,000; 30,001-100,000; 10,001-30,000; 3,001-10,000; 501-3,000; 0-500 |
|
Suppressed; unsuppressed |
Time on ART |
|
|
0-3; 3-6; 6-12; 12-24; 24-36; >36 months |
|
|
|
First or second line ARV regimen |
|
Yes |
Yes |
Yes |
Yes |
Yes |
Disease staging or opportunistic infections |
Tuberculosis, other opportunistic infection, no opportunistic infection |
No-AIDS/ AIDS |
|
Severe bacterial infection; severe fungal infection; severe malaria; tuberculosis; isosporiasis; cerebral toxoplasmosis; nontuberculous mycobacteriosis; other severe opportunistic infection; mild bacterial infection; mild fungal infection; other mild infection |
WHO Stages (1, 2, 3, 4) |
AIDS |
Adverse events |
|
|
|
|
|
Toxicity; no toxicity |